Abbott sees solid medtech growth but cuts outlook
This article was originally published in Clinica
Executive Summary
Abbott Laboratories’ diagnostics and vascular businesses witnessed increased revenues in the first quarter of 2010, carrying on a good performance from the units at the start of 2010.